A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

Prostate cancer relies on genetic "switches," called enhancers, that can turn on tumor-promoting genes. Researchers at the ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...

BERLIN — For men with high-risk biochemically recurrent prostate cancer, adding enzalutamide (Xtandi) to standard androgen ...

Prostate cancer blood tests can lead to men being over-tested, while those who need help may be missed, a large study has ...

Men with genes that increase the risk of prostate cancer should have annual checks from the age of 40, research has shown.

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.

SBRT may ease toxicity, but the lower doses could come at the expense of cancer control, new data indicate. Experts suggest a ...

New research indicates that high levels of folate and vitamin B12 may elevate prostate cancer risk, particularly for ...

Higher serum creatinine levels that are still within normal ranges are associated with a significantly increased risk of prostate cancer, according to a new study. Compared with patients in the lowest ...

Daryl Wilber had his gallbladder removed due to painful gallstones. The regular post-op appointments showed high PSA levels, ...